General Practice · Humacao, PR
NPI
1972908259
Since 2014
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
57 Calle Font Martelo W
Humacao, PR, 00791
Phone (787) 852-1770
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
35,600 prescriptions
Company payments, 2025
$116
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Melvin E Ortiz-Acevedo prescribed most often to Medicare patients was Gabapentin, with 1,867 prescriptions and refills. In total Melvin E Ortiz-Acevedo wrote 35,600 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gabapentin Generic | 1,867 | 2,770 | 346 | $16K |
| Atorvastatin Calcium Generic | 1,601 | 3,530 | 389 | $15K |
| Famotidine Generic | 1,372 | 2,117 | 263 | $9,996 |
| Metformin Hcl Generic | 960 | 2,118 | 221 | $5,738 |
| Amlodipine Besylate Generic | 893 | 1,892 | 212 | $4,236 |
| Simvastatin Generic | 785 | 1,721 | 183 | $4,822 |
| Levothyroxine Sodium Generic | 779 | 1,583 | 166 | $9,652 |
| Omeprazole Generic | 770 | 1,242 | 156 | $4,895 |
| Rosuvastatin Calcium Generic | 724 | 1,668 | 189 | $8,319 |
| Losartan Potassium Generic | 690 | 1,586 | 175 | $8,594 |
| Irbesartan Generic | 681 | 1,309 | 132 | $15K |
| Synthroid Levothyroxine Sodium | 653 | 1,078 | 131 | $51K |
| Pantoprazole Sodium Generic | 629 | 994 | 130 | $5,358 |
| Metoprolol Succinate Generic | 538 | 1,068 | 118 | $7,521 |
| Lisinopril Generic | 528 | 1,286 | 137 | $2,731 |
Brand drugs: 4,513 claims; generic drugs: 30,445 claims; opioid claims: 325.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melvin E Ortiz-Acevedo $116 ($116 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $100.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.